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What is known on this subject
. There is a lack of information on the preferences of renal patients generally for diﬀerent priority criteria
for renal transplantation.
. Ethnic minorities, including South Asians, black Africans and Caribbeans, are more susceptible to renal
disease, and there are lower levels of organ donation in these communities.
. Ethnic-minority groups are therefore disadvantaged if allocation is primarily directed towards recipients
who can be closely tissue matched with donor organs.
What this paper adds
. The analysis provides information about patient preferences and patients’ willingness to decide between
diﬀerent priority criteria for transplantation using discrete choice experiments.
. The analysis demonstrates that SouthAsian and non-white ethnic-minority patients have preferences that
diﬀer from those of other patients, and they would not prioritise patients with closer tissue matches or
younger respondents. This is in contrast to other patients who are not in these ethnic-minority groups.
. Although there is evidence that preferences for prioritising transplants may diﬀer between male and
female patients, gender-related diﬀerences in preferences are not particularly pronounced.
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Introduction
In March 2008, a total of 6784 patients in the UK
awaited renal transplants, but in 2007–2008 only 1249
patients received cadaveric (deceased donor) trans-
plants, and 831 patients received live donor transplants.
The growing imbalance between demand for and supply
of transplants led to the 2008 Transplant Workforce
Report (Department of Health, 2008), which outlined
initiatives to facilitate a 50% increase in cadaveric
transplants within ﬁve years. Despite this, demandwill
exceed supply, especially among members of ethnic-
minority groups who are more susceptible to diseases
linked to renal disease necessitating transplants (Raleigh,
1997; Churak, 2005; Davis and Randhawa, 2006; UK
Transplant, 2006). They are also less likely to obtain
closely matched transplants (Higgins et al, 1997; UK
Transplant, 2006). The increased risk among mem-
bers of ethnic-minority populations, compared with
white patients, of developing end-stage renal disease
(Churak, 2005) is partly related to the higher preva-
lence of type 2 diabetes. A UK study indicates a preva-
lence among blackAfrican andCaribbean patients that
is 3.5 times higher than that among white patients
(Raleigh, 1997). South Asians are also more susceptible
to diabetes and heart failure leading to renal disease
(Bennett and Savani, 2004). Greater demand for renal
transplants in these communities is matched by reduced
rates of organ donation (Bennett and Savani, 2004).
Therefore, systems that prioritise on the basis of donor
and recipient tissue matching will disadvantage some
ethnic groups.
Improved anti-rejection drugs have reduced the
importance of tissue matching in determining trans-
plant success, so other criteria now merit greater con-
sideration (Koene, 2002).Moreover, by applying discrete
choice experiments (DCEs), it is possible to quantify
trade-oﬀs between diﬀerent priority criteria. A DCE
study of this kind has already been undertaken in
relation to liver transplantation (Ratcliﬀe and Buxton,
1999; Ratcliﬀe, 2000a). In this paper we report diﬀer-
ences in preferences between non-white ethnic-minority
patients and other patients, and between South Asian
patients and other patients. We also consider whether
these preferences vary according to gender.
Materials and methods
DCEs involve respondents making a series of choices
about which one of two hypothetical transplant
recipients who diﬀer in their characteristics should
receive a kidney. Using DCEs, the weight that respon-
dents give to diﬀerences in characteristics can be
quantiﬁed. The steps involved in undertaking a DCE
are summarised below.
ABSTRACT
Revisions toUK transplant allocation policy in 2006
marked a policy shift towards ascribing higher
priority to people who had been waiting for a long
time for transplants, and to young adults, at the
expense of emphasising tissue match between donor
and recipient. This beneﬁted members of ethnic
minorities because of a shortage of donors from some
ethnic groups. However, the change was informed
by dated research which was not speciﬁc to the UK,
andwhich failed to address ethnic or gender-related
diﬀerences in preferences.
Preference information was elicited using dis-
crete choice experiment (DCE) questionnaires (in
English, Punjabi, Hindi, Bengali, Gujarati and Urdu)
from 908 patients (508 males and 397 females). Of
the 908 repondents, 96 were members of ethnic-
minority groups, namely white ethnic minorities
(27/908) and non-white ethnicminorities (69/908),
including 50 South Asians. Priority criteria included
length of time spent waiting for a transplant, quality
of the donor–recipient tissue match, number of
adult and/or child dependants of the recipient,
and whether the recipient had diseases that aﬀected
their life expectancy or quality of life.
Econometric results provided evidence that pref-
erences diﬀered slightly according to gender, but
diﬀered to a greater extent according to ethnic origin.
In signiﬁcant contrast to other patients, members of
non-white and South Asian ethnic minorities did
not tend to prioritise recipients with a good tissue
match, nor, unlike patients more generally, did they
tend to prioritise younger recipients. Non-white
and South Asian ethnic minorities were also less
likely to prioritise those with moderate rather than
severe diseases aﬀecting life expectancy. These results
reinforce the case for recognising diﬀerences in
ethnic-minority group preferences in transplant
allocation policy.
Keywords: choice experiment, ethnicity, gender,
renal transplant
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Pilot exercise
We interviewed 60 respondents (including eight
members of ethnic-minority groups), consisting of
41 patients, 16 healthcare professionals, one donor,
one carer and one renal consultant’s secretary. These
respondents completed aDCEquestionnaire and ranked
potential priority criteria for renal transplantation. All
60 respondents in the pilot exercise came from the
University Hospitals of Coventry and Warwickshire
(UHCW) NHS trust.
Attributes and levels: the final DCE
Attributes relate to the diﬀerent hypothetical charac-
teristics of transplant recipients, but these were based
on a qualitative exercise informed by discussions be-
tween the lead researcher, other researchers, the grant-
holder and UHCW medical staﬀ. However, ﬁndings
from the pilot exercise, including the signiﬁcance or
non-signiﬁcance of attributes following data analysis,
respondents’ rankings of attributes in ranking exer-
cises, and their general feedback, informed the selec-
tion of attributes and levels for the ﬁnal questionnaire.
Final attributes and levels included the following:
. Length of time spent waiting for a transplant:
levels included were one month, two years or ten
years. The coeﬃcient on the variable waiting time
indicates utility for each 1-year reduction in
recipient waiting time.
. Quality of tissue match: levels included:
– a non-favourablematchwith an average of 86%
12-month kidney survival post-transplant
– a favourable match with an average of 89% 12-
month kidney survival post-transplant
– a perfect match with an average of 90% 12-
month kidney survival post-transplant.
The coeﬃcient on the variable tissue indicates utility
for each 1% improvement in kidney survival.
. The number of child or adult dependants of the
recipient: levels included zero, one or four depend-
ants. The coeﬃcient on the variable dependant
indicated utility from prioritising to people with
dependants, for each additional dependant.
. Recipient age: levels included 20, 45 or 65 years.
The coeﬃcient on the attribute age indicated utility
for each one-year reduction in recipient age.
. Recipient diseases that affect life expectancy:
– the variable disease1 indicated utility from trans-
planting to a recipient having no diseases, other
than kidney disease, aﬀecting recipient life ex-
pectancy rather than amoderate disease such as
uncontrolled hypertension or obesity plus kidney
disease
– the variable disease2 indicated utility from
transplanting to a recipient having a moderate
disease aﬀecting life expectancy, such as un-
controlled hypertension or obesity, rather than
a severe disease aﬀecting life expectancy, such as
heart attack, diabetes with complications, or
stroke.
The diﬀerence between a person with no disease
aﬀecting their life expectancy and one with severe
disease is the sum of signiﬁcant coeﬃcients on
disease1 and disease2.
. Recipient diseases that affect quality of life:
– the variable ill1 indicated utility from trans-
planting to a recipient having no diseases other
than kidney disease aﬀecting quality of life, rather
than a moderate disease such as mild asthma
with kidney disease
– the variable ill2 indicated utility from trans-
planting to a recipient having a moderate disease
aﬀecting quality of life, such as mild asthma
with kidney disease, rather than a severe disease
aﬀecting quality of life, such as kidney disease
plus severe arthritis.
The diﬀerence between a person with no disease
aﬀecting their quality of life and one with severe
disease is the sum of signiﬁcant coeﬃcients on ill1
and ill2.
Final questionnaire
The DCE design was sourced from leaders in the ﬁeld
(Street et al, 2005). It is a ‘main eﬀects’ design, and
preferences are inferred from 18 choices for speciﬁc
attributes. The design did not involve the use of a
constant comparator. Half of the choices went into
questionnaire version A, the remainder went into
version B, and we distributed equal numbers of each. It
was orthogonal, and checks (Spearman’s and Pearson’s
correlation coeﬃcients) conﬁrmed this. The question-
naire was available in English, Pubjabi, Hindi, Bengali,
Gujarati and Urdu. The questionnaires elicited infor-
mation on gender and posed a question about eth-
nicity (see Figure 1).
Questionnaire distribution
A total of 20 000 ﬂyers with Freepost reply envelopes
were enclosed in the UKNational Kidney Federation’s
publication Kidney Life, inviting people to request
questionnaires, including alternative-language versions
if required. As we did not receive a large enough sample
of ethnic-minority patients from the postal question-
naire, a bilingual researcher (Dr Anil Gumber) obtained
18 additional responses from members of ethnic-
minority groups at EalingNHSTrust andﬁve additional
responses from members of ethnic-minority groups at
University Hospitals of Coventry and Warwickshire
NHS Trust.
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Data analysis
We used model A to compare patient preferences for
non-white ethnic-minority patients versus others
(model 1), South Asian patients versus others (model
2), and female patients versus others (model 3). Yij is a
binary dependent variable, from individuals i = 1...m,
for observations j = 1...ni. Observations ni vary because
the i individuals do not all complete every pairwise
choice (some respondents do not answer all choices),
i is the random eﬀects error term (which allows for
multiple responses from i respondents), and Eij is the
probit error term for individuals i for j observations.
Variables are deﬁned in the Materials and Methods
section. Ds is a dummy variable and is equal to 1 if the
respondent is in the subgroup, otherwise it is equal to 0.
Yi = 0 + 1waitij + 2tissueij + 3dependantij + 4ageij +
5disease1ij + 6disease2ij + 7ill1ij
+ 8ill2ij + 9Ds+ 10Dswaitij + 11Dstissueij +
12Dsdependantij + 13Dsageij
+ 14Dsdisease1ij + 15Dsdisease2ij + 16Dsill1ij +
17Dsill2ij + i + Eij
(Model A: models 1, 2 and 3)
Establishing the marginal rate of
substitution (MRS)
MRS relates changes in attributes to a 1-year change in
waiting time as a ratio. We used the Delta method
(Wooldridge, 2002) to establish whether MRS was
signiﬁcant. This was because the binary dependent
variable model that we used (random eﬀects probit)
was non-linear, and the Delta method can be used to
establish conﬁdence intervals for estimated parameters
for these types of models (Greene, 2000). Moreover,
the approach allows researchers to establish the sig-
niﬁcance or otherwise of a ratio of coeﬃcients. Since
MRS is a ratio, it allows clariﬁcation of whether MRS
for a given variable is signiﬁcant both for the deﬁned
subgroups of patients, and also for patients who are
not in the deﬁned ethnic speciﬁc or female subgroups
(see Table 1). These tests for statistical signiﬁcance
were performed using the command ‘nlcom’ in STATA.
We also performed Wald tests to establish whether
MRS in a subgroup diﬀered in a statistically signiﬁcant
manner from MRS among other patients, in other
wordswhether the non-white ethnicminorities, South
Asian ethnic minorities or female subgroups had a
diﬀerent MRS to other patients who were not in that
Which of the following ethnic groups do you consider that you belong to? (Please tick one box only):
White (British) &
White (Irish) &
White (any other white background)
(please describe) .............................................
&
Mixed (white/black Caribbean) &
Mixed (white/black African) &
Mixed (white/South Asian) &
Any other mixed background
(please describe) .............................................
&
Black or black British (Caribbean) &
Black or black British (African) &
Black or black British (any other background) &
South Asian or South Asian British (Indian) &
South Asian or South Asian British (Pakistani) &
South Asian or South Asian British (Bangladeshi) &
South Asian or South Asian British (any other
background)
&
Chinese &
Any other ethnic group
(please describe) ............................................
&
Figure 1 Details of ethnicity categories presented to questionnaire respondents
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subgroup. So, for example, in relation to the variable
tissue, the test we conducted was whether 2/1 = (2
+ 11)/(1 + 10). These tests were performed using
the command ‘testnl’ in STATA. Wald tests establish
whether there is a signiﬁcant diﬀerence in MRS com-
paringMRS for base groups, versus deﬁned subgroups
for each attribute. Diﬀerences in MRS at the 5% level
are indicated by P-values of  0.05.
Results
Sample characteristics
The UK National Kidney Federation, which publishes
Kidney Life, could not provide us with data that might
allow us to assess the representativeness of our sample,
so instead we used data from the UK Renal Registry
(Farrington et al, 2008a,b).
In total, 895 out of 908 respondents indicated their
ethnic origin. Of these, 799 out of 895 patients (89.3%)
were white (British), and 27 out of 908 (3%) were mem-
bers of white ethnicminorities, so overall 92.3% of our
sample was white. This compares with incidence data
(Farrington et al, 2008a) which suggest that, across the
UK, 79.8%of renal patients are white, so in our sample
white patients were over-represented. Moreover, 69 out
of 895 patients (7.7%) were members of non-white
ethnicminorities, comparedwith a 17.9% incidence rate
(Farrington et al, 2008a). Of the 69 members of non-
white ethnic minorities, 50 patients were of South
Asian origin. Therefore, 50 of the 895 patients in our
sample (5.6%) were of South Asian origin, compared
with a 10% incidence rate (Farrington et al, 2008a).
Members of non-white ethnic minorities consisted
of two out of 69 mixed (white/black Caribbean), one
out of 69 mixed (white/black African), one out of 69
mixed (white South Asian), two out of 69 with any
other mixed background, including a Luso-Indian,
one out of 69 Anglo-Indian/English-Portugese. In total,
seven out of 69 were black or black British Caribbean,
three out of 69 were black or black British (African),
one out of 69 was black or black British (any other
background), and two patients were Chinese.
The 50 South Asian patients in the non-white
sample included 29 out of 69 South Asian or South
Asian British (Indian) patients, nine out of 69 South
Asian or South Asian British (Pakistani) patients,
two out of 69 South Asian or South Asian British
Bangladeshi patients, seven out of 69 South Asian or
South Asian British (any other background) patients,
plus one Filipina, one Persian and one Iranian patient.
In total, 508 out of 908 patients (55.9%) were male,
397 out of 908 patients (43.7%)were female, and three
out of 908 patients (0.3%) did not indicate their gender.
This is reassuring, as Renal Registry data that have been
presented graphically (Farrington et al, 2008a) show a
trend towards slightly higher proportions ofmen than
women among renal patients for all age groups.
The average patient age was 54.88 years (median 57
years). For members of white ethnic minorites the
average age was 55.65 years (median 57 years), for
those belonging to non-white ethnic minorities it was
54.12 years (median 56 years), and for patients of
South Asian origin it was 55.38 years (median 56.5
years). Amongmale patients (508/908) the average age
was 56.49 years (median 58 years), and among female
patients (397/908) it was 52.85 years (median 54 years).
Unfortunately the Renal Registry data (Farrington et al,
2008b) are not speciﬁc for ethnic origin or gender.
However, the median age for all patients is 56.9 years,
which is remarkably close to our ﬁgure of 57 years.
Table 1 Calculation of MRS
Variable Base group MRS Variable MRS for subgroup of
respondents
Waiting time N/A Waiting time N/A
Tissue B2/1 Tissue (2 + 11)/(1 + 10)
Dependant B3/1 Dependant (3 + 12)/(1 + 10)
Age B4/1 Age (4 + 13)/(1 + 10)
Disease1 B5/1 Disease1 (5 + 14)/(1 + 10)
Disease2 B6/1 Disease2 (6 + 15)/(1 + 10)
Ill1 B7/1 Ill1 (7 + 16)/(1 + 10)
Ill2 B8/1 Ill2 (8 + 17)/(1 + 10)
N/A, not applicable.
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The sample consisted of 468 out of 908 patients
(51.5%) with successful transplants, 118 out of 908
patients (13%) whose transplant failed, and 279 out of
908 patients (30.7%) who were awaiting transplants,
with an average waiting period of 22.6 months. Some
patients whose transplant failed are also included in
the data for those awaiting transplants. This also
applies to all gender and ethnic-minority groups. A
total of 237 out of 908 patients (26.3%) were on dialysis
without transplantation, and 57 out of 908 patients
(6.3%) had kidney disease that did not require dialysis.
Renal Registry prevalence data (Farrington et al, 2008b)
suggest that 46.6% of patients have successful trans-
plants (as this is their current treatment modality),
which is reassuringly close to our ﬁgure. However,
there are nodata for patientswith failed transplants, or
for those awaiting transplants, on dialysis without
transplantation, or with kidney disease not requiring
transplantation. Among non-white ethnic minorities
there were 18 out of 69 patients (26%) with successful
transplants, 10 out of 69 patients (14.5%) whose trans-
plant failed, 35 out of 69 patients (50.7%) awaiting a
transplant on dialysis (average waiting period 21.45
months), and three out of 69 patients (4.3%) with
kidney disease not requiring dialysis. Among those of
South Asian origin, 10 out of 50 patients (20%) had
successful transplants, eight out of 50 patients (16%)
had failed transplants, 28 out of 50 patients (56%)
were awaiting transplants (averagewaiting period 23.1
months), and three out of 50 patients (6%) were on
dialysis without transplantation. Unfortunately, the
availabledata (Farrington et al, 2008b)werenot analysed
by ethnic origin. However, given the shortage of trans-
plants available to ethnic-minority groups, and their
lower success rates, because they are likely to be poorer
tissue matches, the lower percentage ﬁgure for trans-
plant successes and the higher percentage ﬁgure for
transplant failures might be expected.
Data analysis
The results for models 1 to 3 are presented in Tables 2,
3 and 4.
Table 2 Model 1: patients – dummy variables for non-white ethnic-minority patients
Attribute Coeﬃcient
excluding
non-white
ethnic
minorities
MRS excluding
non-white ethnic
minorities
Coeﬃcient for
dummy
variables for
non-white
ethnic
minorities
MRS for non-white
ethnic minorities
Wald test
(P-value)
Waiting time 0.448** 1 –0.0025 1
Tissue 0.690** 1.54** (1.19/1.89) –0.0718** –0.07 (–1.13/1.00) < 0.001
Dependant 0.0605** 1.35** (1.08/1.62) 0.03450 2.26** (1.16/3.36) 0.311
Age 0.0074** 0.16** (0.13/0.20) –0.0045 0.07 (–0.05/0.19) < 0.001
Disease1 0.0067 0.15 (–0.90/1.21) –0.0773 –1.67 (–5.55/2.21) 0.375
Disease2 0.7138** 15.93** (13.96/17.91) –0.3649** 8.25** (2.86/13.64) < 0.001
Ill1 –0.1113** –2.48** (–1.16/–3.81) –0.1049 –5.11* (–0.45/–9.78) 0.992
Ill2 0.1829** 4.08** (2.99/5.18) 0.0263 4.95* (0.97/8.92) 0.149
Intercepts 0.1306** –0.0952
Percentage of
actual values
predicted:
62.64% Sample: 908 patients
(69 are non-
white ethnic
minorities)
McFadden’s R2: 0.113
LR test (l): 29.14 Dummy variables
jointly signiﬁcant?
Yes: CV for 9
dfs = 16.92
Log-likelihood: –4987.2
* Denotes signiﬁcance at 1% level.
** Denotes signiﬁcance at 5% level but not at 1% level.
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Non-white ethnic-minority patients vs.
other patients
The likelihood ratio test for model 1 (see Table 2) is
signiﬁcant, which suggests that preferences do vary
between members of non-white ethnic minorities and
other patients. The Wald tests for three variables are
also signiﬁcant, which suggests that MRS diﬀers sig-
niﬁcantly between the two patient groups for these
three variables. For non-white ethnicminorities, MRS
on the variable tissue is non-signiﬁcant. This relates to
prioritising recipients with a good tissue match, so
members of non-white ethnic minorities would not
prioritise to recipients with better tissue matches. For
other patients it is positive and signiﬁcant, implying a
preference for prioritising recipients with better tissue
matches. Another diﬀerence relates to age. Among
members of non-white ethnic minorities the variable
age is non-signiﬁcant, so they would not prioritise
younger recipients, whereas among other patients this
variable is positive and signiﬁcant, suggesting a pref-
erence for prioritising younger recipients. Finally, there
is evidence that preferences vary in relation to prior-
itising those with diseases that aﬀect life expectancy.
The variable disease2 relates to prioritising those with
moderate rather than severe diseases that aﬀect life
expectancy. Members of non-white ethnic minorities
place less emphasis than do other patients on prior-
itising those withmoderate rather than severe diseases
that aﬀect life expectancy (MRS = 8.25 vs. 15.93).
South Asian patients vs. other patients
A similar pattern emerges in the South Asian patient
sample (see Table 3), which is not unexpected, as they
represented a large proportion (50 out of 69) of the
non-white ethnic-minority group. Once again likeli-
hood ratio tests suggest that preferences do vary
between the two patient groups, and the Wald tests
suggest that these diﬀerences relate to the same three
variables. There is no evidence that South Asian patients
would prioritise those with a better tissue match, as
the variable tissue is non-signiﬁcant. However, among
other patients, the variable is positive and signiﬁcant,
which suggests a preference for prioritising recipients
with better tissuematches. SouthAsian patientswould
Table 3 Model 2: patients – dummy variables for South Asian patients
Attribute Coeﬃcient
excluding
South
Asian
ethnic
minorities
MRS excluding
South Asian ethnic
minorities
Coeﬃcient for
South Asian
ethnic
minorities
MRS for South Asian
ethnic minorities
Wald test
(P-value)
Waiting time 0.0450** 1 –0.0069 1
Tissue 0.0681** 1.51** (1.17/1.85) –0.0824** –0.38 (–1.74/0.99) 0.001
Dependant 0.0609** 1.36** (1.09/1.62) 0.0386 2.61** (1.07/4.16) 0.434
Age 0.0073** 0.16** (0.13/0.20) –0.0055 0.048 (–0.11/0.21) 0.002
Disease1 0.0023 0.05 (–0.99/1.08) –0.0243 –0.58 (–5.58/4.43) 0.803
Disease2 0.7095** 15.78** (13.84/17.71) –0.4214** 7.57* (0.71/14.42) < 0.001
Ill1 –0.1119** –2.49** (–1.19/–3.80) –0.1371 –6.54* (–0.42/–12.65) 0.827
Ill2 0.1807** 4.02** (2.94/5.10) 0.0785 6.81* (1.49/12.12) 0.417
Intercepts 0.1286** –0.0932
Percentage of
actual values
predicted:
62.71% Sample: 908 patients
(50 are South
Asian ethnic
minorities)
McFadden’s R2: 0.113
LR test (l): 27.76 Dummy variables
jointly signiﬁcant?
Yes: CV for 9
dfs = 16.92
Log-likelihood: –4987.85
* Denotes signiﬁcance at 1% level.
** Denotes signiﬁcance at 5% level but not at 1% level.
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not prioritise the young rather than the old, as the
variable age is non-signiﬁcant, whereas among other
patients it is positive and signiﬁcant. Finally, although
both South Asian patients and the rest of the patient
sample would prioritise those with moderate rather
than severe diseases that aﬀect life expectancy, South
Asian patients would be less likely to prioritise on the
basis of this criterion (MRS = 7.57 vs. 15.78).
Preferences and gender
The results of the likelihood ratio test do not provide
evidence of a diﬀerence in preferences between male
and female patients (see Table 4). However,Wald tests
suggest that preferences may vary in relation to four
out of eight variables. These tests suggest that prefer-
ences may vary in relation to prioritising on the basis
of tissuematch (tissue). Bothmale and female patients
valued this criterion signiﬁcantly. However, it appears
that females value it marginally more than do males
(MRS = 1.45 vs. 1.34). TheWald test also suggests that
preferences diﬀer with regard to prioritising recipients
with child or adult dependants. The variable depend-
ant is signiﬁcant for both groups, but female patients
appear to value this marginally more (MRS = 1.61 vs.
1.28). The Wald test suggests that preferences for
prioritising younger rather than older dependantsmight
also diﬀer. Female patients place marginally more em-
phasis on this variable (age) than domales (MRS = 0.17
vs. 0.14). Finally, both female and male patients value
prioritising those with severe rather than moderate
diseases that aﬀect life expectancy (disease2) signiﬁcantly.
However, this variable seems to be valued marginally
less by female patients (MRS = 14.86 vs. 15.43).
These ﬁndings suggest that patients who are not
members of ethnic minorities value prioritising patients
with closer tissuematches, whereas South Asian patients
and those from non-white ethnic minorities do not.
Patients in general, including those who belong to
ethnicminorities, prioritise thosewhohave had towait a
long time for a transplant, and those with child or adult
dependants. However, prioritising younger people is
not valued among South Asians and non-white ethnic
minorities, whereas it is among other patients. Those
with moderate rather than severe diseases that aﬀect
life expectancy are a priority for patients in general,
but less of a priority among South Asian patients and
non-white ethnic minorities. All ethnic groups value
prioritising those with moderate as opposed to no
diseases that aﬀect quality of life. This may seem a
somewhat odd result, but it could be explained by
enlightened self-interest, in that many respondents
themselves would have moderate diseases, in addition
Table 4 Model 3: patients with female patient dummy variables
Attribute Coeﬃcient
for male
patients
MRS for male
patients
Coeﬃcient for
female patients
MRS for female
patients
Wald test
(P-value)
Waiting time 0.0448** 1 –0.0003 1
Tissue 0.0603** 1.34** (0.90/1.78) 0.0045 1.45** (0.95/1.96) 0.009
Dependant 0.0575** 1.28** (0.94/1.62) 0.0141 1.61** (1.20/2.01) 0.014
Age 0.0064** 0.14** (0.10/0.19) 0.0011 0.17** (0.11/0.22) 0.026
Disease1 –0.0373 –0.83 (–2.21/0.54) 0.0704 0.74 (–0.80/2.28) 0.137
Disease2 0.6917** 15.43** (12.91/17.93) –0.0295 14.86** (12.07/17.64) <0.001
Ill1 –0.1150** –2.56** (–0.85/–4.27) –0.0131 –2.87** (–0.94/–4.80) 0.285
Ill2 0.1615** 3.60** (2.19/5.01) 0.0520 4.79** (3.18/6.40) 0.175
Intercepts 0.1144** 0.0201
Percentage of
actual values
predicted:
62.50% Sample: 908 patients
(397 are female)
McFadden’s R2: 0.110
LR test (l): 5.00 Dummy variables
jointly signiﬁcant?
No: CV for 9
dfs = 16.92
Log-likelihood: –4908.40
* Denotes signiﬁcance at 1% level.
** Denotes signiﬁcance at 5% level but not at 1% level.
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to kidney disease, which aﬀect their quality of life. More-
over, there is no evidence that the ethnic-minority
groups value prioritising those with moderate rather
than severe diseases that aﬀect quality of life diﬀerently.
Both groups would prioritise potential recipients with
moderate rather than severe diseases that aﬀect quality
of life.
Although there is evidence that preferences vary
according to gender, these diﬀerences are not particu-
larly pronounced. However, women do have a slightly
greater tendency to prioritise recipients who are better
tissue matches to donors. Women are also slightly more
likely to prioritise those with child or adult depend-
ants, and younger people, and slightly less likely to
prioritise those with moderate rather than severe
diseases that aﬀect life expectancy.
Discussion
Discrete choice experiments (DCEs), sometimes re-
ferred to as conjoint analysis (Ryan and Farrar, 2000),
are increasingly used in health technology assessment
(Ryan, 1999) and health economics (Ryan andGerard,
2003). Indeed, searches on PubMed have identiﬁed
several hundredhealth-relatedDCEs.However, although
some DCEs have addressed the concerns of ethnic
minorities (Bennett and Savani, 2004; Dwight-Johnson
et al, 2004; Byrne et al, 2006; Hall et al, 2006; Peacock
et al, 2006; Hawley et al, 2008; Sung-Jae et al, 2008;
Constantinesgu et al, 2009), themajority have assessed
preferences for respondents overall, rather than for
minority groups. Only a very fewDCEs have looked at
gender-related issues (Brown et al, 2003; Mays and
Zimet, 2004; Tsang et al, 2004; Kjaer et al, 2006;
Hjelmgren and Anell, 2007; Gerard et al, 2008).
DCEs have strong theoretical foundations in econ-
omics. They are compatible with Lancaster’s charac-
teristics theory of demand (Lancaster, 1966) and random
utility theory (McFadden, 1999). They are often used
to establish how much people are willing to pay for
diﬀerent attributes of healthcare provision. However,
there are methodological issues which need to be
addressed before it can be assumed thatDCE estimates
of willingness to pay (WTP) are accurate (Ryan et al,
1998; Ratcliﬀe, 2000b; Ryan and Farrar, 2000; Ryan
et al, 2003). One major concern is that if they are
applied in a context in which healthcare is free at the
point of use, respondents may indicate an unreal-
istically high WTP, because they know that they will
not in fact bear a cost, leading to hypothetical bias.
Alternatively, theymay concealWTP because they feel
the questionmay be a precursor to the introduction of
charging, leading to strategic bias.
We did not elicit WTP, thereby avoiding many of
these problems. However, it must be conceded that
our results are sensitive to the choice of attributes
selected, and can only give an indication of trade-oﬀs
in relation to the actual attributes included. Since there
are no deﬁnitive criteria for establishing the appropri-
ate attributes and levels to include in a DCE, researchers
simply have to consult a wide range of opinion, in-
cluding patients andprofessionals, before deciding upon
the attributes and levels, and ensure that the choice of
attributes is defensible.
Although DCEs have been applied to determine
priorities for liver transplants (Ratcliﬀe and Buxton,
1999; Ratcliﬀe, 2000a), that UK study did not collect
ethnicity data, only gender data. The study reported
diﬀerences in responses by gender, but the data were
not analysed to establish whether preferences varied
with gender. The only other DCE work in the area of
transplantation is another UK study of factors that
inﬂuence people’s willingness to donate body parts for
transplantation in the event of their death (Bennett
and Savani, 2004). This considered three groups (white,
South Asian and Afro-Caribbean), but concluded that
‘being of a particular ethnicity or gender did not aﬀect
outcomes in anymeaningfulways’, so theyonly reported
results for respondents overall (Bennett and Savani,
2004, p. 76).
In the ﬁeld of transplantation there are of course
other studies which do not use DCE methodology.
Other kidney allocation studies were conducted in
Australia and America (Louis et al, 1997; Browning
and Thomas, 2001), and may not be generalisable to
theUK. The Australian study (Browning and Thomas,
2001) involved 238 respondents ranking possible pri-
ority criteria for transplantation, including age, gender,
occupation, education, work status, income, whether
potential recipients were parents, post-transplantation
prognosis, and length of time for which recipients had
been on the transplant list. They therefore avoided
addressing the issue of whether to prioritise on the
basis of ethnicity. They found that over 90% of 238
respondents considered that recipient gender, socio-
economic status, employment status and occupation
should not inﬂuence decisions about kidney trans-
plant allocation. Instead, most of the respondents
(87.4%) considered that those who had been on the
transplant list for a long period of time should have
priority, and 79% would prioritise those with a good
prognosis, whilst 65%would prioritise younger recip-
ients.
The American study (Louis et al, 1997) noted that
the American point-based allocation system disadvan-
taged African Americans because of its emphasis on
antigenmatching, as African Americans typically have
a disproportionate number of rare antigens. They used
semi-structured interviews with 33 patients who were
awaiting transplants, including some black Americans
who considered that discrimination in organ allocation
by antigen matching was unfair. However, there was a
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paradox in that they did not want to receive organs
that gave them a reduced likelihood of survival. So
these results diﬀer from ours, but of course the rate of
graft survival has increased since the American study
because of improvements in anti-rejection drugs,
so this may explain the diﬀerences in ﬁndings. The
authors did not address the issue of gender-related
diﬀerences.
There is one other study (Geddes et al, 2005), which
was conducted in Scotland. A total of 295 respondents
were asked to choose one of two hypothetical patients
from eight scenarios to establish whether the patients
agreed with the current criteria for transplant alloca-
tion in the UK. Ethnicity was not taken into consider-
ation in this research, although gender was addressed.
The ﬁndings suggested that neither age nor gender of
the recipient should be used when making decisions
about the allocation of kidneys. The latter ﬁnding is
somewhat at odds with our ﬁndings for the non-
ethnic-minority patients, who, unlike the ethnic min-
orities, would tend to prioritise younger recipients.
This research was conducted prior to the UK Trans-
plant 2006 reforms to transplant allocation criteria.
It seemed to broadly support a shift away from the
previous emphasis on tissue matching. It showed that
only 24.6% of 295 respondents agreed with UK trans-
plant policy at a time when the survival advantage of
transplanting to a recipient whose transplantwould be
a closermatch to the donor justiﬁed transplanting to a
patient who had waited for only two years rather than
seven years. The main conclusion was that allocation
should favour respondents who had waited for longer,
and of course UK transplant policy did evolve to place
more emphasis on those who have waited a long time
for a transplant.
Conclusions
Our ﬁndings are broadly supportive of revisions toUK
transplant kidney allocation policy in 2006, which
reduced the emphasis on transplanting to patients
with good tissue matches. However, although the policy
shift places less emphasis on tissue matching as an
allocation criterion, current policy still retains quality
of tissuematching as an allocation criterion. Although
this might be supported by the majority of patients,
evidence from this research suggests that it would not
be supported by South Asians and members of non-
white ethnic minorities more generally. Non-white
ethnic minorities and South Asians would prefer the
quality of tissue type matching between donor and
recipient to be abandoned as a criterion for allocation.
They are disadvantaged if transplant allocation is based
on tissue matching, which no doubt accounts for this
ﬁnding.UKTransplant’s policy shift towards prioritising
those who have waited a long time for a transplant is
supported by these ﬁndings for all ethnic-minority
groups, irrespective of gender. However, the other
shift in emphasis, towards prioritising younger patients,
does not appear to be supported by ethnic-minoritiy
groups, although it is supported by other patients.
Although we have found some evidence that prefer-
ences do vary with gender, these diﬀerences are not
particularly pronounced, which suggests that an at-
tempt to facilitate the preferences of people according
to gender is a low priority, and that addressing the
speciﬁc needs and disadvantages of ethnic-minority
groups should be a more urgent consideration when
transplant policy is reassessed.
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